Current immunological and molecular tools for leptospirosis: Diagnostics, vaccine design, and biomarkers for predicting severity

Annals of Clinical Microbiology and Antimicrobials

Volumn 14, Issue 1, 2015, Pages

  Rajapakse, Senaka ^a   Rodrigo, Chaturaka ^a   Handunnetti, Shiroma M ^b   Fernando, Deepika ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Biomarkers; Diagnosis; Leptospirosis; Vaccine

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA INTERFERON; GRANZYME B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; LEPTOSPIROSIS VACCINE; NITRATE; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL VACCINE;

CLINICAL FEATURE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MICROSCOPY; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ANIMAL; BLOOD; GENETIC PROCEDURES; GENETICS; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEPTOSPIRA; MICROBIOLOGY; PROCEDURES;

ANIMALS; BACTERIAL VACCINES; BIOMARKERS; GENETIC TECHNIQUES; HUMANS; IMMUNOASSAY; LEPTOSPIRA; LEPTOSPIROSIS;

EID: 84924406142     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-014-0060-2     Document Type: Review

References (51)

1. Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis. 2008;12(4):351-7.
2. Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: an emerging global public health problem. J Biosci. 2008;33(4):557-69.
3. Global burden of leptospirosis. Leptospirosis Burden Epidemiology Reference Group. [http://www.who.int/zoonoses/diseases/lerg/en/index2.html]. Accessed 15th January 2015.
4. Spichler AS, Vilaca PJ, Athanazio DA, Albuquerque JO, Buzzar M, Castro B, et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg. 2008;79(6):911-4.
5. Chandrasekaran S, Gomathi S. A standard screening test for the early and rapid diagnosis of leptospirosis. Indian J Med Microbiol. 2004;22(1):23-7.
6. Sharma KK, Kalawat U. Early diagnosis of leptospirosis by conventional methods: one-year prospective study. Indian J Pathol Microbiol. 2008;51(2):209-11.
7. Boonyod D, Poovorawan Y, Bhattarakosol P, Chirathaworn C. LipL32, an outer membrane protein of Leptospira, as an antigen in a dipstick assay for diagnosis of leptospirosis. Asian Pac J Allergy Immunol. 2005;23(2-3):133-41.
8. Tahiliani P, Kumar MM, Chandu D, Kumar A, Nagaraj C, Nandi D. Gel purified LipL32: a prospective antigen for detection of leptospirosis. J Postgrad Med. 2005;51(3):164-8.
9. Coutinho ML, Vasconcellos FA, Fernandes CP, Seyffert N, Seixas FK, Ko AI, et al. Evaluation of the anti-LipL32 monoclonal antibodies potential for use in leptospirosis immunodiagnostic tests. J Immunoassay Immunochem. 2007;28(3):279-88.
10. Dey S, Mohan CM, Ramadass P, Nachimuthu K. Diagnosis of leptospirosis by recombinant antigen based single serum dilution ELISA. Indian J Med Res. 2008;128(2):172-7.
11. Neves FO, Abreu PA, Vasconcellos SA, de Morais ZM, Romero EC, Nascimento AL. Identification of a novel potential antigen for early-phase serodiagnosis of leptospirosis. Arch Microbiol. 2007;188(5):523-32.
12. Natarajaseenivasan K, Vijayachari P, Sharma S, Sugunan AP, Selvin J, Sehgal SC. Serodiagnosis of severe leptospirosis: evaluation of ELISA based on the recombinant OmpL1 or LipL41 antigens of Leptospira interrogans serovar autumnalis. Ann Trop Med Parasitol. 2008;102(8):699-708.
13. Senthilkumar T, Subathra M, Phil M, Ramadass P, Ramaswamy V. Rapid serodiagnosis of leptospirosis by latex agglutination test and flow-through assay. Indian J Med Microbiol. 2008;26(1):45-9.
14. Srimanote P, Wongdeethai N, Jieanampunkul P, Samonkiert S, Leepiyasakulchai C, Kalambaheti T, et al. Recombinant ligA for leptospirosis diagnosis and ligA among the Leptospira spp. clinical isolates. J Microbiol Methods. 2008;72(1):73-81.
15. Aviat F, Rochereau-Roulet S, Branger C, Estavoyer JM, Chatrenet B, Orsonneau JL, et al. Synthetic peptide issued from Hap1/LipL32 for new early serodiagnosis of human leptospirosis. Comp Immunol Microbiol Infect Dis. 2010;33(5):375-87.
16. Chalayon P, Chanket P, Boonchawalit T, Chattanadee S, Srimanote P, Kalambaheti T. Leptospirosis serodiagnosis by ELISA based on recombinant outer membrane protein. Trans R Soc Trop Med Hyg. 2011;105(5):289-97.
17. Lin X, Chen Y, Yan J. Recombinant multiepitope protein for diagnosis of leptospirosis. Clin Vaccine Immunol. 2008;15(11):1711-4.
18. Sun A, Wang Y, Du P, Wu S, Yan J. A sensitive and specific IgM-ELISA for the serological diagnosis of human leptospirosis using a rLipL32/1-LipL21-OmpL1/2 fusion protein. Biomed Environ Sci. 2011;24(3):291-9.
19. Signorini ML, Lottersberger J, Tarabla HD, Vanasco NB. Enzyme-linked immunosorbent assay to diagnose human leptospirosis: a meta-analysis of the published literature. Epidemiol Infect. 2013;141(1):22-32.
20. Goris MG, Leeflang MM, Loden M, Wagenaar JF, Klatser PR, Hartskeerl RA, et al. Prospective evaluation of three rapid diagnostic tests for diagnosis of human leptospirosis. PLoS Negl Trop Dis. 2013;7(7):e2290.
21. Limmathurotsakul D, Turner EL, Wuthiekanun V, Thaipadungpanit J, Suputtamongkol Y, Chierakul W, et al. Fool's gold: why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis. Clin Infect Dis. 2012;55(3):322-31.
22. Gravekamp C, Van de Kemp H, Franzen M, Carrington D, Schoone GJ, Van Eys GJ, et al. Detection of seven species of pathogenic leptospires by PCR using two sets of primers. J Gen Microbiol. 1993;139(8):1691-700.
23. de Abreu FC, de Freitas VLT, Calo Romero E, Spinosa C, Arroyo Sanches MC, da Silva MV, et al. Polymerase chain reaction in comparison with serological tests for early diagnosis of human leptospirosis. Trop Med Int Health. 2006;11(11):1699-707.
24. Ooteman MC, Vago AR, Koury MC. Evaluation of MAT, IgM ELISA and PCR methods for the diagnosis of human leptospirosis. J Microbiol Methods. 2006;65(2):247-57.
25. Thaipadungpanit J, Chierakul W, Wuthiekanun V, Limmathurotsakul D, Amornchai P, Boonslip S, et al. Diagnostic accuracy of real-time PCR assays targeting 16S rRNA and lipL32 genes for human leptospirosis in Thailand: a case-control study. PLoS One. 2011;6(1):e16236.
26. Agampodi SB, Matthias MA, Moreno AC, Vinetz JM. Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: association of level of leptospiremia and clinical manifestations in Sri Lanka. Clin Infect Dis. 2012;54(9):1249-55.
27. Koizumi N, Watanabe H. Leptospirosis vaccines: past, present, and future. J Postgrad Med. 2005;51(3):210-4.
28. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine. 2007;25(33):6277-86.
29. Hartwig DD, Forster KM, Oliveira TL, Amaral M, McBride AJ, Dellagostin OA. A prime-boost strategy using the novel vaccine candidate, LemA, protected hamsters against leptospirosis. Clin Vaccine Immunol. 2013;20(5):747-52.
30. Seixas FK, Fernandes CH, Hartwig DD, Conceicao FR, Aleixo JA, Dellagostin OA. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Can J Microbiol. 2007;53(4):472-9.
31. Forster KM, Hartwig DD, Seixas FK, Bacelo KL, Amaral M, Hartleben CP, et al. A conserved region of leptospiral immunoglobulin-like (Lig) A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol. 2013;20(5):725-31.
32. Dellagostin OA, Grassmann AA, Hartwig DD, Felix SR, da Silva EF, McBride AJ. Recombinant vaccines against leptospirosis. Hum Vaccin. 2011;7(11):1215-24.
33. Cao Y, Faisal SM, Yan W, Chang YC, McDonough SP, Zhang N, et al. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model. Vaccine. 2011;29(43):7379-86.
34. Grassmann AA, Felix SR, dos Santos CX, Amaral MG, Seixas Neto AC, Fagundes MQ, et al. Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin. Clin Vaccine Immunol. 2012;19(5):740-5.
35. Gamberini M, Gomez RM, Atzingen MV, Martins EA, Vasconcellos SA, Romero EC, et al. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett. 2005;244(2):305-13.
36. Yan W, Faisal SM, McDonough SP, Chang CF, Pan MJ, Akey B, et al. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis. Vaccine. 2010;28(11):2277-83.
37. Atzingen MV, Vieira ML, Oliveira R, Domingos RF, Mendes RS, Barros AT, et al. Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis. Open Microbiol J. 2012;6:79-87.
38. Maciel EA, Athanazio DA, Reis EA, Cunha FQ, Queiroz A, Almeida D, et al. High serum nitric oxide levels in patients with severe leptospirosis. Acta Trop. 2006;100(3):256-60.
39. Gunaratna RI, Handunnetti SM, Bulathsinghalage MR, Somaratne P, Jayanaga A, de Silva HJ, et al. Serum nitrite levels in Sri Lankan patients with leptospirosis. Asian Pac J Trop Med. 2012;5(1):75-8.
40. Kalugalage T, Rodrigo C, Vithanage T, Somaratne P, De Silva HJ, Handunnetti S, et al. Low serum total nitrite and nitrate levels in severe leptospirosis. BMC Infect Dis. 2013;13(1):206.
41. Pretre G, Olivera N, Cedola M, Haase S, Alberdi L, Brihuega B, et al. Role of inducible nitric oxide synthase in the pathogenesis of experimental leptospirosis. Microb Pathog. 2011;51(3):203-8.
42. De Fost M, Chierakul W, Limpaiboon R, Dondorp A, White NJ, van Der Poll T. Release of granzymes and chemokines in Thai patients with leptospirosis. Clin Microbiol Infect. 2007;13(4):433-6.
43. Kositanont U, Saetun P, Krittanai C, Doungchawee G, Tribuddharat C, Thongboonkerd V. Application of immunoproteomics to leptospirosis: towards clinical diagnostics and vaccine discovery. Proteomics Clin Appl. 2007;1(4):400-9.
44. Thongboonkerd V. Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development. Expert Rev Mol Diagn. 2008;8(1):53-61.
45. Srivastava R, Ray S, Vaibhav V, Gollapalli K, Jhaveri T, Taur S, et al. Serum profiling of leptospirosis patients to investigate proteomic alterations. J Proteomics. 2012;76 Spec No:56-68.
46. Fialho RN, Martins L, Pinheiro JP, Bettencourt BF, Couto AR, Santos MR, et al. Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis. Hum Immunol. 2009;70(11):915-20.
47. Miranda KA, Vasconcelos LR, Coelho LC, Lima Filho JL, Cavalcanti MS, Moura P. High levels of serum mannose-binding lectin are associated with the severity of clinical signs of leptospirosis. Braz J Med Biol Res. 2009;42(4):353-7.
48. Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T, et al. Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis. PLoS Negl Trop Dis. 2009;3(6):e453.
49. Wagenaar JF, Goris MG, Gasem MH, Isbandrio B, Moalli F, Mantovani A, et al. Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect. 2009;58(6):425-32.
50. Limper M, Goeijenbier M, Wagenaar JF, Gasem MH, Isbandrio B, Kunde J, et al. Copeptin as a predictor of disease severity and survival in leptospirosis. J Infect. 2010;61(1):92-4.
51. Adler B, Lo M, Seemann T, Murray GL. Pathogenesis of leptospirosis: the influence of genomics. Vet Microbiol. 2011;153(1-2):73-81.